Srinivasan Yegnasubramanian Selected Research

Formaldehyde (Formol)

1/2018	ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.
6/2014	Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Srinivasan Yegnasubramanian Research Topics

Disease

71	Neoplasms (Cancer) 05/2024 - 03/2004
62	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 02/2004
12	Adenocarcinoma 04/2024 - 04/2011
10	Carcinogenesis 11/2019 - 02/2004
8	Prostatic Intraepithelial Neoplasia 11/2023 - 02/2004
6	Atrophy 04/2024 - 02/2004
6	Inflammation (Inflammations) 01/2019 - 08/2009
4	Virus Diseases (Viral Diseases) 10/2023 - 10/2016
4	COVID-19 03/2022 - 10/2020
4	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 12/2005
3	Glioma (Gliomas) 03/2023 - 01/2012
3	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2004
3	Neoplasm Metastasis (Metastasis) 01/2019 - 10/2015
2	Carcinoma (Carcinomatosis) 04/2024 - 01/2018
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2023 - 01/2023
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2023 - 01/2023
2	Infections 01/2023 - 01/2015
2	Pneumonia (Pneumonitis) 03/2022 - 05/2015
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 05/2015
2	Human Influenza (Influenza) 01/2021 - 10/2020
2	Squamous Cell Carcinoma of Head and Neck 11/2020 - 01/2020
2	Prostatitis 01/2019 - 10/2016
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2018 - 11/2008
2	Leukemia 01/2016 - 05/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Thyroiditis 12/2022

Drug/Important Bio-Agent (IBA)

36	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 02/2004
17	Androgen Receptors (Androgen Receptor)IBA 12/2023 - 09/2009
16	AndrogensIBA 01/2024 - 09/2009
16	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2004
14	Proteins (Proteins, Gene)FDA Link 04/2024 - 05/2005
10	Phenobarbital (Luminal)FDA Link 11/2023 - 02/2010
10	RNA (Ribonucleic Acid)IBA 10/2023 - 08/2012
10	ChromatinIBA 01/2021 - 06/2004
9	MethyltransferasesIBA 07/2023 - 05/2005
8	Messenger RNA (mRNA)IBA 01/2021 - 06/2004
5	LigandsIBA 12/2023 - 07/2012
5	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2019
5	Hormones (Hormone)IBA 01/2022 - 02/2008
5	Transcription Factors (Transcription Factor)IBA 12/2021 - 09/2009
5	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2021 - 02/2004
5	hydrogen sulfite (bisulfite)IBA 10/2020 - 02/2004
5	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 06/2005
4	Testosterone (Sustanon)FDA Link 01/2024 - 01/2015
4	VaccinesIBA 12/2023 - 03/2022
4	Decitabine FDA Link 01/2023 - 05/2015
4	CytosineIBA 01/2023 - 05/2005
4	Histones (Histone)IBA 01/2021 - 06/2013
3	Cell-Free Nucleic AcidsIBA 12/2023 - 06/2005
3	A-Form DNA (A-DNA)IBA 12/2023 - 03/2011
3	Azacitidine (5 Azacytidine)FDA Link 07/2023 - 06/2016
3	enzalutamideIBA 12/2022 - 07/2012
3	EnzymesIBA 01/2019 - 05/2007
3	5-hydroxymethylcytosineIBA 01/2016 - 08/2011
3	MicroRNAs (MicroRNA)IBA 08/2012 - 09/2009
2	Serine Proteases (Serine Protease)IBA 04/2024 - 08/2010
2	Mitochondrial DNA (mtDNA)IBA 11/2023 - 03/2023
2	AntigensIBA 01/2023 - 11/2008
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 01/2023 - 01/2021
2	Cetuximab (Erbitux)FDA Link 11/2020 - 01/2020
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2020 - 01/2018
2	B7-H1 AntigenIBA 01/2020 - 01/2018
2	CytokinesIBA 01/2019 - 10/2016
2	InterleukinsIBA 01/2019 - 10/2016
2	AntibodiesIBA 01/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 10/2018 - 01/2018
2	ParaffinIBA 01/2018 - 06/2014
2	Formaldehyde (Formol)FDA Link 01/2018 - 06/2014
2	NucleosidesIBA 06/2016 - 03/2011
2	Protein Isoforms (Isoforms)IBA 03/2015 - 08/2010
2	CarcinogensIBA 01/2014 - 01/2013
2	AminesIBA 01/2014 - 01/2013
2	DNA Restriction Enzymes (Restriction Endonuclease)IBA 06/2005 - 02/2004
1	ProdrugsIBA 05/2024
1	Glutamine (L-Glutamine)FDA Link 05/2024
1	JHU083IBA 05/2024
1	NivolumabIBA 01/2024
1	Flutamide (Eulexin)FDA LinkGeneric 12/2023
1	Dihydrotestosterone (Androstanolone)IBA 12/2023
1	Cancer VaccinesIBA 12/2023
1	Small Cytoplasmic RNAIBA 10/2023
1	Chemokine ReceptorsIBA 07/2023
1	ChemokinesIBA 03/2023
1	Glutathione S-Transferase piIBA 01/2023
1	Granzymes (Granzyme)IBA 01/2023
1	GuanineIBA 01/2023
1	Gemcitabine FDA Link 01/2023
1	Broadly Neutralizing AntibodiesIBA 01/2023
1	Therapeutic UsesIBA 12/2022
1	IodineIBA 12/2022

Therapy/Procedure

21	Therapeutics 01/2024 - 09/2009
13	Castration 01/2024 - 09/2009
9	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 06/2005
5	Radiotherapy 12/2023 - 02/2010
3	Immunotherapy 01/2021 - 10/2019
3	Drug Therapy (Chemotherapy) 05/2017 - 06/2004
2	Chemoprevention 01/2013 - 08/2009